)
Cryoport (CYRX) investor relations material
Cryoport Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved FY2025 revenue of $176.2 million, up 12% year-over-year and above prior guidance, reflecting strong momentum in core markets and leadership in cell and gene therapy.
Supported 760 active cell and gene therapy clinical trials and 20 commercial therapies by year-end, maintaining approximately 70% market share in CGT clinical trials.
Strategic partnership with DHL completed, including the sale of CRYOPDP, resulting in a significant capital infusion and CRYOPDP financials now reported as discontinued operations.
Expanded global partnerships and footprint with Cardinal Health, Parexel, and new supply chain centers in Paris and Santa Ana.
Ended FY2025 with $411 million in cash and short-term investments, positioning for future growth.
Financial highlights
FY2025 total revenue grew 12% year-over-year to $176.2 million; Q4 revenue increased 10% year-over-year.
Gross margin improved to 47.1% for FY2025, up from 44.4% in FY2024.
Adjusted EBITDA improved by $12 million year-over-year, reaching $(5.8) million for FY2025.
Life Sciences Services revenue grew 18% year-over-year; BioStorage/BioServices up 22%; Life Sciences Products revenue increased 7%.
Net income for FY2025 was $78.3 million, driven by a $112.3 million gain from the CRYOPDP divestiture.
Outlook and guidance
FY2026 revenue guidance is $190–$194 million, representing 8–10% year-over-year growth.
Positive adjusted EBITDA anticipated in the second half of 2026.
Expecting 9 new therapy approvals, 13 BLA/MAA filings, and 2 label/geographic expansions in 2026.
Commercial therapy revenue expected to be the primary growth driver, with continued double-digit growth in services and mid- to high-single digit growth in products.
Guidance is subject to macroeconomic, geopolitical, and industry-specific risks.
Next Cryoport earnings date
Next Cryoport earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)